|
1
|
Zagouri F, Sergentanis TN, Tsigginou A,
Dimitrakakis C, Zografos GC, Dimopoulos MA and Psaltopoulou T:
Female breast cancer in Europe: Statistics, diagnosis and treatment
modalities. J Thorac Dis. 6:589–590. 2014.PubMed/NCBI
|
|
2
|
Majeed W, Aslam B, Javed I, Khaliq T,
Muhammad F, Ali A and Raza A: Breast cancer: Major risk factors and
recent developments in treatment. Asian Pac J Cancer Prev.
15:3353–3358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lum JJ, Bauer DE, Kong M, Harris MH, Li C,
Lindsten T and Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell. 120:237–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi WY, Xiao D, Wang L, Dong LH, Yan ZX,
Shen ZX, Chen SJ, Chen Y and Zhao WL: Therapeutic metformin/AMPK
activation blocked lymphoma cell growth via inhibition of mTOR
pathway and induction of autophagy. Cell Death Dis. 3:e2752012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Corcelle E, Djerbi N, Mari M, Nebout M,
Fiorini C, Fénichel P, Hofman P, Poujeol P and Mograbi B: Control
of the autophagy maturation step by the MAPK ERK and p38: Lessons
from environmental carcinogens. Autophagy. 3:57–59. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang B, Zhu R, Tian S, Wang Y, Lou S and
Zhao H: Jatamanvaltrate P induces cell cycle arrest, apoptosis and
autophagy in human breast cancer cells in vitro and in vivo. Biomed
Pharmacother. 89:1027–1036. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dirsch VM, Kiemer AK, Wagner H and Vollmar
AM: The triterpenoid quinonemethide pristimerin inhibits induction
of inducible nitric oxide synthase in murine macrophages. Eur J
Pharmacol. 336:211–217. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yousef BA, Hassan HM, Guerram M, Hamdi AM,
Wang B, Zhang LY and Jiang ZZ: Pristimerin inhibits proliferation,
migration and invasion and induces apoptosis in HCT-116 colorectal
cancer cells. Biomed Pharmacother. 79:112–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu YB, Gao X, Deeb D, Pindolia K and
Gautam SC: Role of telomerase in anticancer activity of pristimerin
in prostate cancer cells. J Exp Ther Oncol. 11:41–49.
2015.PubMed/NCBI
|
|
12
|
Yousef BA, Guerram M, Hassan HM, Hamdi AM,
Zhang LY and Jiang ZZ: Pristimerin demonstrates anticancer
potential in colorectal cancer cells by inducing G1 phase arrest
and apoptosis and suppressing various pro-survival signaling
proteins. Oncol Rep. 35:1091–1100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee JS, Yoon IS, Lee MS, Cha EY, Thuong
PT, Diep TT and Kim JR: Anticancer activity of pristimerin in
epidermal growth factor receptor 2-positive SKBR3 human breast
cancer cells. Biol Pharm Bull. 36:316–325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang H, Landis-Piwowar KR, Lu D, Yuan P,
Li L, Reddy GP, Yuan X and Dou QP: Pristimerin induces apoptosis by
targeting the proteasome in prostate cancer cells. J Cell Biochem.
103:234–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu CC, Chan ML, Chen WY, Tsai CY, Chang FR
and Wu YC: Pristimerin induces caspase-dependent apoptosis in
MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer
Ther. 4:1277–1285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klimaszewska-Wisniewska A,
Halas-Wisniewska M, Tadrowski T, Gagat M, Grzanka D and Grzanka A:
Paclitaxel and the dietary flavonoid fisetin: A synergistic
combination that induces mitotic catastrophe and autophagic cell
death in A549 non-small cell lung cancer cells. Cancer Cell Int.
16:102016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Veldhoen RA, Banman SL, Hemmerling DR,
Odsen R, Simmen T, Simmonds AJ, Underhill DA and Goping IS: The
chemotherapeutic agent paclitaxel inhibits autophagy through two
distinct mechanisms that regulate apoptosis. Oncogene. 32:736–746.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Corcelle E, Djerbi N, Mari M, Nebout M,
Fiorini C, Fénichel P, Hofman P, Poujeol P and Mograbi B: Control
of the autophagy maturation step by the MAPK ERK and p38: Lessons
from environmental carcinogens. Autophagy. 3:57–59. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holliday DL and Speirs V: Choosing the
right cell line for breast cancer research. Breast Cancer Res.
13:2152011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shirota O, Morita H, Takeya K and Itokawa
H: Cytotoxic aromatic triterpenes from Maytenus ilicifolia and
Maytenus chuchuhuasca. J Nat Prod. 57:1675–1681. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salminen A, Lehtonen M, Suuronen T,
Kaarniranta K and Huuskonen J: Terpenoids: Natural inhibitors of
NF-kappaB signaling with anti-inflammatory and anticancer
potential. Cell Mol Life Sci. 65:2979–2999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dai X, Liu J, Nian Y, Qiu MH, Luo Y and
Zhang J: A novel cycloartane triterpenoid from Cimicifuga induces
apoptotic and autophagic cell death in human colon cancer HT-29
cells. Oncol Rep. 37:2079–2086. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang D, Gao C, Li R, Zhang L and Tian J:
TEOA, a triterpenoid from Actinidia eriantha, induces autophagy in
SW620 cells via endoplasmic reticulum stress and ROS-dependent
mitophagy. Arch Pharm Res. 40:579–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hen S, Zhang Y, Zhang R, Tu X and Gong X:
Ursolic acid induces autophagy in U87MG cells via ROS-dependent
endoplasmic reticulum stress. Chem Biol Interact. 218:28–41. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng JR, Bai LY, Chiu CF, Hu JL, Chiu SJ
and Wu CY: Cucurbitane Triterpenoid from Momordica charantia
Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part,
through Peroxisome Proliferator-Activated Receptor γ Activation.
Evid Based Complement Alternat Med. 2013:9356752013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen HY and White E: Role of autophagy in
cancer prevention. Cancer Prev Res (Phila). 4:973–983. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Denton D, Nicolson S and Kumar S: Cell
death by autophagy: Facts and apparent artefacts. Cell Death
Differ. 19:87–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dank M, Budi L, Piko B, Mangel L, Erfan J,
Cseh J, Ruzsa A and Landherr L: First-line bevacizumab-paclitaxel
in 220 patients with metastatic breast cancer: Results from the
AVAREG study. Anticancer Res. 34:1275–1280. 2014.PubMed/NCBI
|
|
30
|
Guo Y, Huang C, Li G, Chen T, Li J and
Huang Z: Paxilitaxel induces apoptosis accompanied by protective
autophagy in osteosarcoma cells through hypoxia-inducible factor-1α
pathway. Mol Med Rep. 12:3681–3687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zambrano J and Yeh ES: Autophagy and
apoptotic crosstalk: Mechanism of therapeutic resistance in
HER2-positive breast cancer. Breast Cancer (Auckl). 10:13–23.
2016.PubMed/NCBI
|
|
32
|
Chi EY, Viriyapak B, Kwack HS, Lee YK, Kim
SI, Lee KH and Park TC: Regulation of paclitaxel-induced programmed
cell death by autophagic induction: A model for cervical cancer.
Obstet Gynecol Sci. 56:84–92. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu C, Zhang W, Zheng G, Zhang Z, Yin J and
He Z: Metformin reverses multidrug resistance and
epithelial-mesenchymal transition (EMT) via activating
AMP-activated protein kinase (AMPK) in human breast cancer cells.
Mol Cell Biochem. 386:63–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koziara JM, Whisman TR, Tseng MT and
Mumper RJ: In-vivo efficacy of novel paclitaxel nanoparticles in
paclitaxel-resistant human colorectal tumors. J Control Release.
112:312–319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eum DY, Byun JY, Yoon CH, Seo WD, Park KH,
Lee JH, Chung HY, An S, Suh Y, Kim MJ and Lee SJ: Triterpenoid
pristimerin synergizes with taxol to induce cervical cancer cell
death through reactive oxygen species-mediated mitochondrial
dysfunction. Anticancer Drugs. 22:763–773. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma L, Chen Z, Erdjument-Bromage H, Tempst
P and Pandolfi PP: Phosphorylation and functional inactivation of
TSC2 by Erk implications for tuberous sclerosis and cancer
pathogenesis. Cell. 121:179–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Nie H, Zhao X, Qin Y and Gong X:
Bicyclol induces cell cycle arrest and autophagy in HepG2 human
hepatocellular carcinoma cells through the PI3K/AKT and
Ras/Raf/MEK/ERK pathways. BMC Cancer. 16:7422016. View Article : Google Scholar : PubMed/NCBI
|
